Cerianna FDA Approval History
Last updated by Judith Stewart, BPharm on June 24, 2020.
FDA Approved: Yes (First approved May 20, 2020)
Brand name: Cerianna
Generic name: fluoroestradiol F18
Dosage form: Injection
Company: Zionexa USA
Treatment for: Diagnosis and Investigation
Cerianna (fluoroestradiol F18) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.
Development timeline for Cerianna
| Date | Article |
|---|---|
| May 27, 2020 | Approval FDA Approves Cerianna (fluoroestradiol F18) PET Imaging Agent for Use in Patients with Recurrent or Metastatic Breast Cancer |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
